Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
Transplantation and Cellular Therapy|April 25, 2021
Prolonged Lenalidomide Therapy Does Not Impact Autologous Peripheral Blood Stem Cell Mobilization and Collection in Multiple Myeloma Patients: A Single-Center Retrospective AnalysisAndrew J Cowan, Philip A Stevenson, Damian J Green, et al.
Blood Cancer Journal|February 6, 2019
Molecular underpinnings of clinical disparity patterns in African American vs. Caucasian American multiple myeloma patientsDickran Kazandjian, Elizabeth Hill, Malin Hultcrantz, et al.
Bone Marrow Transplantation|May 6, 2018
Combination therapy with carfilzomib, lenalidomide and dexamethasone (KRd) results in an unprecedented purity of the stem cell graft in newly diagnosed patients with myelomaNishant Tageja, Neha Korde, Dickran Kazandjian, et al.
American Journal of Clinical Oncology|November 8, 2022
Radiographic Response of Solitary Plasmacytomas After Conformal Radiotherapy May Be Delayed: Outcomes in the 3D EraSamuel Kosydar, Avanti Gulhane, Edward Libby, et al.
Blood Reviews|June 30, 2026
MRD in multiple myeloma: Moving from "minimal" to "measurable"Raffaella Cassano Cassano, Rahul Banerjee, Aimaz Afrough, et al.
British Journal of Haematology|March 22, 2016
Monoclonal gammopathy-associated pure red cell aplasiaNeha Korde, Yong Zhang, Kelsey Loeliger, et al.
Leukemia & Lymphoma|August 10, 2017
Host-related immunodeficiency in the development of multiple myelomaTalib Dosani, Sham Mailankody, Neha Korde, et al.
Informatics in Medicine Unlocked|November 4, 2024
SEETrials: Leveraging large language models for safety and efficacy extraction in oncology clinical trialsKyeryoung Lee, Hunki Paek, Liang-Chin Huang, et al.
Medrxiv : the Preprint Server for Health Sciences|May 27, 2024
SEETrials: Leveraging Large Language Models for Safety and Efficacy Extraction in Oncology Clinical TrialsKyeryoung Lee, Hunki Paek, Liang-Chin Huang, et al.
Haematologica|June 19, 2025
Extramedullary disease is associated with severe toxicities following B-cell maturation antigen CAR T-cell therapy in multiple myelomaAndrew J Portuguese, Emily C Liang, Jennifer J Huang, et al.
Pageof 3